CLINICAL SIGNIFICANT P-GLYCOPROTEIN DRUG INTERACTIONS?

被引：0
|
作者：
Lee, Caroline A. [1 ]
Fenner, Katherine S. [2 ]
Kempshall, Sarah [2 ]
Cook, Jack [3 ]
Ware, Joseph Alan [4 ]
Troutman, Matthew D. [5 ]
机构：
[1] Pfizer Inc, La Jolla Labs, Dept PDM, San Diego, CA 92121 USA
[2] Pfizer Global Res & Dev, Pharmacokinet Dynam & Metab, Sandwich, Kent, England
[3] Pfizer, Clin Pharmacol, New London, CT 06320 USA
[4] Pfizer Global Rsch & Develop, Dept PKDM, Ann Arbor, MI 48105 USA
[5] Pfizer Inc, Dept PDM, Groton, CT 06340 USA
来源：
DRUG METABOLISM REVIEWS | 2008年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
316
引用
收藏
页码：208 / 208
页数：1
相关论文
共 50 条
  • [41] The role of P-glycoprotein and organic anion-transporting polypeptides in drug interactions
    DuBuske, LM
    DRUG SAFETY, 2005, 28 (09) : 789 - 801
  • [42] The Role of P-Glycoprotein and Organic Anion-Transporting Polypeptides in Drug Interactions
    Lawrence M. DuBuske
    Drug Safety, 2005, 28 : 789 - 801
  • [43] Unravelling the complex drug-drug interactions of the cardiovascular drugs, verapamil and digoxin, with P-glycoprotein
    Ledwitch, Kaitlyn V.
    Barnes, Robert W.
    Roberts, Arthur G.
    BIOSCIENCE REPORTS, 2016, 36
  • [44] Role of P-glycoprotein in the brain disposition of seletalisib: Evaluation of the potential for drug-drug interactions
    Nicolas, Jean-Marie
    Chanteux, Hugues
    Nicolai, Johan
    Brouta, Frederic
    Viot, Delphine
    Rosseels, Marie-Luce
    Gillent, Eric
    Bonnaillie, Pierre
    Mathy, Francois-Xavier
    Long, Jeff
    Helmer, Eric
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 142
  • [45] Drug–Drug Interactions of a Novel κ-Opioid Receptor Agonist, Nalfurafine Hydrochloride, Involving the P-Glycoprotein
    Akihiro Ando
    Shinichiro Sasago
    Yoshihiro Ohzone
    Yohei Miyamoto
    European Journal of Drug Metabolism and Pharmacokinetics, 2016, 41 : 549 - 558
  • [46] Interactions between artemisinin derivatives and P-glycoprotein
    Wang, Yulin
    Li, Yongjie
    Shang, Dong
    Efferth, Thomas
    PHYTOMEDICINE, 2019, 60
  • [47] Drug-Drug Interactions Mediated Through P-Glycoprotein: Clinical Relevance and In Vitro-In Vivo Correlation Using Digoxin as a Probe Drug
    Fenner, K. S.
    Troutman, M. D.
    Kempshall, S.
    Cook, J. A.
    Ware, J. A.
    Smith, D. A.
    Lee, C. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 (02) : 173 - 181
  • [48] In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system
    Feng, Bo
    Mills, Jessica B.
    Davidson, Ralph E.
    Mireles, Rouchelle J.
    Janiszewski, John S.
    Troutman, Matthew D.
    de Morais, Sonia M.
    DRUG METABOLISM AND DISPOSITION, 2008, 36 (02) : 268 - 275
  • [49] RECONSTITUTION OF DRUG TRANSPORT BY PURIFIED P-GLYCOPROTEIN
    SHAPIRO, AB
    LING, V
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (27) : 16167 - 16175
  • [50] Importance of P-glycoprotein for drug disposition in humans
    Fromm, MF
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2003, 33 : 6 - 9
12345